Lenacapavir: the scientific discovery of the year

It provides nearly 100 percent protection against HIV, which still affects a million people each year, especially in Africa.

Lenacapavir: the scientific discovery of the year

Il Lenacapavir, one of the most used drugs for HIV patients, has been proclaimed by the magazine Science la scientific discovery of the year 2024The reason is clear: this drug, which has proven effective when HIV patients are resistant to other specific therapies, can guarantee excellent prevention coverage against the virus, which still affects one million people each year, especially in Africa.

According to clinical studies, protection reaches 100 percent in the case of African women, and stops at 99 percent in the case of men.

Among the advantages of this drug are two aspects that should not be underestimated. Lenacapavir, unlike other anti-HIV drugs that must be taken every day, It is administered only twice a yearSecondly, some studies already demonstrate its potential for application to other types of infections. Given these assumptions, lenacapavir could prove to be the winning weapon against AIDS (until the early 1990s, HIV-positive people were considered doomed) and other infectious diseases, provided its distribution and availability are guaranteed at affordable prices for African populations.

Read also:

Opening photo of Kaboompics.com via Pexels

Want to see a selection of our news?